logo
Select company
Select metric
$ -13.84MEarning Before Interest & Taxes (EBIT)
VS
Market
27
Sector
59
Industry
73
History
90
$ 6.64Close
$ 6.64 - $ 42.98 52-Week Range
Ticker Information

Ticker

TVRD

Company Name

TVARDI THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TVARDI THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TVRD - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -13.84M
3/31/2025$ -36.12M
12/31/2024$ -62.79M
9/30/2024$ -89.07M
6/30/2024$ -106.58M
3/31/2024$ -119.96M
12/31/2023$ -117.91M
9/30/2023$ -116.52M
6/30/2023$ -111.66M
3/31/2023$ -84.39M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TVARDI THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -99.71M.
  • Over the past 5 years, TVARDI THERAPEUTICS INC's average EBIT has been $ -66.37M.
  • The median EBIT for TVARDI THERAPEUTICS INC during this period was $ -86.96M
  • TVARDI THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ 23.59M.
  • The lowest EBIT recorded by TVARDI THERAPEUTICS INC in the same timeframe $ -119.96M

TVARDI THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
CRBU : CARIBOU BIOSCIENCES INC $ -164.27MKRRO : KORRO BIO INC $ -91.26MOCGN : OCUGEN INC $ -54.97MTCRX : TSCAN THERAPEUTICS INC $ -133.66MLCTX : LINEAGE CELL THERAPEUTICS INC $ -40.91MACOG : ALPHA COGNITION INC $ -19.92MOVID : OVID THERAPEUTICS INC $ -38.18MCRVO : CERVOMED INC $ -22.61MQSI : QUANTUM-SI INC $ -106.37MFATE : FATE THERAPEUTICS INC $ -171.52M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

TVRD - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -119.96M

Minimum

Mar 31, 2024

$ 23.59M

Maximum

Sep 30, 2021

$ -66.37M

Average

$ -86.96M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.48M with a standard deviation of $ 130.48M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442M
average$ 28.48M
median$ 847.86K
std$ 130.48M